Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 12 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Annovis Bio Inc | ANVS | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 11.09 | 08:07:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.09 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 3 | 12 | - | 5.42 - 22.49 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:04:41 | 10 | $ 11.10 | USD |
Annovis Bio (ANVS) Options Flow Summary
Annovis Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 113.81M | 10.26M | - | 0 | -25.33M | -2.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Annovis Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ANVS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.55 | 12.3349 | 10.85 | 11.62 | 130,751 | -0.46 | -3.98% |
| 1 Month | 9.34 | 13.26 | 8.90 | 11.35 | 296,064 | 1.75 | 18.74% |
| 3 Months | 11.90 | 13.26 | 8.1001 | 10.42 | 241,629 | -0.81 | -6.81% |
| 6 Months | 7.76 | 22.49 | 5.42 | 11.32 | 249,461 | 3.33 | 42.91% |
| 1 Year | 15.09 | 22.49 | 5.42 | 11.46 | 142,636 | -4.00 | -26.51% |
| 3 Years | 21.75 | 132.00 | 5.42 | 44.32 | 253,960 | -10.66 | -49.01% |
| 5 Years | 8.9875 | 132.00 | 2.418 | 33.88 | 260,160 | 2.10 | 23.39% |
Annovis Bio Description
| Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. |
